Protocols
1 protocol(s) meet the specified criteria
Drug: MEDI9197
Protocol No.TitleStatus
D6410C00001A Phase I, First-Time-in Human Study of MEDI9197, a TLR 7/8 Agonist, Administered Intratumorally in Subjects with Solid Tumor CancerOpen